Evidence-based therapies for sepsis care in the emergency department: Striking a balance between feasibility and necessity

Academic Emergency Medicine

Volumn 13, Issue 1, 2006, Pages 82-83

  Jones, Alan E ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; CORTICOSTEROID; RECOMBINANT PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COLON CANCER; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH CARE COST; HUMAN; LUNG CANCER; MORTALITY; NOTE; PRIORITY JOURNAL; SEPSIS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 29244441182     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2005.09.002     Document Type: Editorial

References (11)

1. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
2. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, by race/ethnicity, 1998-2002. HIV/AIDS Surveillance Supplemental Report. 2003; 10:1-38.
3. American Cancer Society Cancer Facts and Figures 2003 2003 ACS Atlanta, GA
4. American Heart Association Heart Disease and Stroke Statistics - 2004 Update 2003 AHA Dallas, TX
5. K.D. Kochanek, and B. Smith Deaths: preliminary data for 2002 Natl Vital Stat Rep 52 13 2004 1 32
6. E. Rivers, B. Nguyen, and S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368 1377
7. D. Annane, V. Sebille, and C. Charpentier Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 288 2002 862 871
8. G.R. Bernard, J.L. Vincent, and P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
9. R.P. Dellinger, J.M. Carlet, and H. Masur Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 32 2004 858 873
10. H.B. Nguyen, S.W. Corbett, K. Menes, T. Cho, T. Daugharthy, W. Klein, and W.A. Wittlake Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department Acad Emerg Med 13 2006 109 113
11. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829